Matt Hibbard is Money Morning’s income specialist.
With nearly three decades in the markets, Matt has traded just about every asset class there is. The one thing that has stuck with him over this time is a very simple premise. That is, it’s the cash a company generates that ultimately determines its value.
Sure, some stocks might fly away to multi-digit gains. But unless these companies can convert the ‘story’ into real money, the market will eventually find them out. And when that happens, the share price quickly falls back to Earth.
That’s why, over at Total Income, Matt is on the hunt for the next generation of dividend-payers. Stocks that should be able to pay their shareholders reliable and rising dividends into the future.
Matt is also the editor of Options Trader, where he shows subscribers how to use basic options strategies to generate income. This is income they can generate on top of regular dividend payments.
Matt doesn’t play the prediction game, where the aim is to be proven ‘right’. Instead, his goal is to generate as much income as he can for his subscribers, irrespective of whether the market is going up or down.
There is perhaps nothing in the financial markets that attracts more jargon than options. From weird and wonderful strategies, through to even the most basic definitions. It can put you off before you even begin.
Kogan.com Limited’s [ASX:KGN] share price continues to plummet this morning following yesterday’s massive 33% drop. At time of writing, Kogan shares down 70% since its record high of $9.85 on 16 March 2018.
Sometimes, buying into a former high-flying stock that is wallowing at a fraction of an earlier price, can be too tempting to pass up. You do the usual mug’s mental gymnastics: Yep, it’s fallen a lot…it looks cheap…surely it can’t go much lower than this...
There is another way to play this market. It enables you to take a position in either direction. You can also set up a trade that captures a move, whichever way it goes. And how do we do that? Through the use of option trading.
Wesfarmers Limited's [ASX:WES] share price is up slightly this morning, following the release of its first quarter results for 2019 this morning.
Zelda Therapeutics Ltd’s [ASX:ZLD] share price is yet to move despite announcing its new autism observation trial. The Australian-based bio-pharmaceutical company is focused on developing cannabis-based treatments for a variety of medical conditions.This morning Wesfarmers Limited [ASX:WES] requested its shares be placed in a trading halt, pending an announcement related to the demerger of its Coles supermarket chain.
Babylon Pump & Power Limited’s [ASX:BPP] share price could be set to rise this morning after the company secured a new contract with BHP Billiton [ASX:BHP].
P2P Transport Ltd’s [ASX:P2P] share price has fallen more than 40% since listing on the ASX on 13 December 2017.
Westpac Banking Corporation’s [ASX:WBC] share price rose 32 cents on Friday 28 September, despite the bank releasing a profit warning after the market had closed on Thursday afternoon.